Skip to main content
Erschienen in: Pediatric Cardiology 4/2011

01.04.2011 | Original Article

P-Wave Dispersion and Heart Rate Variability in Children with Mitral Valve Prolapse

verfasst von: Kadir Babaoglu, Gürkan Altun, Köksal Binnetoğlu

Erschienen in: Pediatric Cardiology | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Previous studies have reported that patients with mitral valve prolapse (MVP) may display autonomic dysfunction. Measurement of heart rate variability (HRV) and P-wave dispersion (PWD) may provide insights into the functional state of the autonomic nervous system. Heart rate variability (HRV) has been used as a noninvasive marker of autonomic activity. However, to the authors’ knowledge, PWD has not been studied in the context of MVP. This study aimed to examine HRV and PWD in patients with MVP and to determine whether differences exist between symptomatic and asymptomatic patients. The study population consisted of 54 healthy children (17 boys and 37 girls) ages 6–18 years and 76 patients with MVP (20 boys and 56 girls) ages 6–18 years. The duration and dispersion of the P-wave were measured by surface 12-lead electrocardiograms (ECGs). Heart rate variability was quantified using both time-domain and frequency-domain analyses of Holter ECGs. The minimum duration of the P-wave was significantly lower in the MVP patients (42.4 ± 10.0 ms) than in the control subjects (54.4 ± 12.8 ms) (p < 0.01), and the PWD was significantly increased in the MVP group (42.7 ± 10.8 ms) compared with the control subjects (31.8 ± 10.9 ms) (p < 0.01). However, no significant differences were found between the symptomatic and asymptomatic patients. In addition, the HRV parameters were not statistically different between the two groups. In conclusion, although HRV parameters were not significantly different between the MVP and control groups, the findings show that PWD was increased for the children with MVP. However, no relationship could be established between PWD and clinical symptoms.
Literatur
1.
Zurück zum Zitat American College of Cardiology/American Heart Association (1998) ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 32:1486–1588CrossRef American College of Cardiology/American Heart Association (1998) ACC/AHA guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 32:1486–1588CrossRef
2.
Zurück zum Zitat Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF (1980) Metabolic studies in mitral valve prolapse syndrome: a neuroendocrine–cardiovascular process. Circulation 61:1200–1205PubMed Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF (1980) Metabolic studies in mitral valve prolapse syndrome: a neuroendocrine–cardiovascular process. Circulation 61:1200–1205PubMed
3.
Zurück zum Zitat Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF (1983) Mitral valve prolapse syndrome: the effect of adrenergic stimulation. J Am Coll Cardiol 2:638–644PubMedCrossRef Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF (1983) Mitral valve prolapse syndrome: the effect of adrenergic stimulation. J Am Coll Cardiol 2:638–644PubMedCrossRef
4.
Zurück zum Zitat Cheema AN, Ahmed MW, Kadish AH, Goldberger JJ (1995) Effects of autonomic stimulation and blockade on signal-averaged P-wave duration. J Am Coll Cardiol 26:497–502PubMedCrossRef Cheema AN, Ahmed MW, Kadish AH, Goldberger JJ (1995) Effects of autonomic stimulation and blockade on signal-averaged P-wave duration. J Am Coll Cardiol 26:497–502PubMedCrossRef
5.
Zurück zum Zitat Davies AO, Mares A, Pool JL, Taylor AA (1987) Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity: beta 2-adrenergic receptor supercoupling with desensitization on isoproterenol exposure. Am J Med 82:193–201PubMedCrossRef Davies AO, Mares A, Pool JL, Taylor AA (1987) Mitral valve prolapse with symptoms of beta-adrenergic hypersensitivity: beta 2-adrenergic receptor supercoupling with desensitization on isoproterenol exposure. Am J Med 82:193–201PubMedCrossRef
6.
Zurück zum Zitat Devereux RB, Jones EC, Roman MJ, Howard BV, Fabsitz RR, Liu JE, Palmieri V, Welty TK, Lee ET (2001) Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the strong heart study. Am J Med 111:679–685PubMedCrossRef Devereux RB, Jones EC, Roman MJ, Howard BV, Fabsitz RR, Liu JE, Palmieri V, Welty TK, Lee ET (2001) Prevalence and correlates of mitral valve prolapse in a population-based sample of American Indians: the strong heart study. Am J Med 111:679–685PubMedCrossRef
7.
Zurück zum Zitat Digeos-Hasnier S, Copie X, Paziaud O, Abergel E, Guize L, Diebold B, Jeunemaître X, Berrebi A, Piot O, Lavergne T, Le Heuzey JY (2005) Abnormalities of ventricular repolarization in mitral valve prolapse. Ann Noninvasive Electrocardiol 10:297–304PubMedCrossRef Digeos-Hasnier S, Copie X, Paziaud O, Abergel E, Guize L, Diebold B, Jeunemaître X, Berrebi A, Piot O, Lavergne T, Le Heuzey JY (2005) Abnormalities of ventricular repolarization in mitral valve prolapse. Ann Noninvasive Electrocardiol 10:297–304PubMedCrossRef
8.
Zurück zum Zitat Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, Toutouzas PK (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135:733–738PubMedCrossRef Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, Kyriakidis M, Gialafos JE, Toutouzas PK (1998) Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 135:733–738PubMedCrossRef
9.
Zurück zum Zitat Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ (1999) Prevalence and clinical outcome of mitral valve prolapse. N Engl J Med 341:1–7PubMedCrossRef Freed LA, Levy D, Levine RA, Larson MG, Evans JC, Fuller DL, Lehman B, Benjamin EJ (1999) Prevalence and clinical outcome of mitral valve prolapse. N Engl J Med 341:1–7PubMedCrossRef
10.
Zurück zum Zitat Frisinghelli A, Turiel M, Milletich A, Crema C, Malliani A (1992) The role of mitral regurgitation in the neurovegetative regulation of mitral valve prolapse. Cardiologia 37:781–783PubMed Frisinghelli A, Turiel M, Milletich A, Crema C, Malliani A (1992) The role of mitral regurgitation in the neurovegetative regulation of mitral valve prolapse. Cardiologia 37:781–783PubMed
11.
Zurück zum Zitat Gaffney FA, Karlsson ES, Campbell W, Schutte JE, Nixon JV, Willerson JT, Blomqvist CG (1979) Autonomic dysfunction in women with mitral valve prolapse syndrome. Circulation 59:894–901PubMed Gaffney FA, Karlsson ES, Campbell W, Schutte JE, Nixon JV, Willerson JT, Blomqvist CG (1979) Autonomic dysfunction in women with mitral valve prolapse syndrome. Circulation 59:894–901PubMed
12.
Zurück zum Zitat Gaffney FA, Bastian BC, Lane LB, Taylor WF, Horton J, Schutte JE, Graham RM, Pettinger W, Blomqvist CG (1983) Abnormal cardiovascular regulation in the mitral valve prolapse syndrome. Am J Cardiol 52:316–320PubMedCrossRef Gaffney FA, Bastian BC, Lane LB, Taylor WF, Horton J, Schutte JE, Graham RM, Pettinger W, Blomqvist CG (1983) Abnormal cardiovascular regulation in the mitral valve prolapse syndrome. Am J Cardiol 52:316–320PubMedCrossRef
13.
Zurück zum Zitat Gunduz H, Arinc H, Kayardi M, Akdemir R, Ozyildirim S, Uyan C (2006) Heart rate turbulence and heart rate variability in patients with mitral valve prolapse. Europace 8:515–520PubMedCrossRef Gunduz H, Arinc H, Kayardi M, Akdemir R, Ozyildirim S, Uyan C (2006) Heart rate turbulence and heart rate variability in patients with mitral valve prolapse. Europace 8:515–520PubMedCrossRef
14.
Zurück zum Zitat Han L, Ho TF, Yip WC, Chan KY (2000) Heart rate variability of children with mitral valve prolapse. J Electrocardiol 33:219–224PubMedCrossRef Han L, Ho TF, Yip WC, Chan KY (2000) Heart rate variability of children with mitral valve prolapse. J Electrocardiol 33:219–224PubMedCrossRef
15.
Zurück zum Zitat Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, Gatewood RP Jr (1987) Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 75:175–183PubMed Helmcke F, Nanda NC, Hsiung MC, Soto B, Adey CK, Goyal RG, Gatewood RP Jr (1987) Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation 75:175–183PubMed
16.
Zurück zum Zitat Josephson ME, Kastor JA, Morganroth J (1977) Electrocardiographic left atrial enlargement: electrophysiologic, echocardiographic, and hemodynamic correlates. Am J Cardiol 39:967–971PubMedCrossRef Josephson ME, Kastor JA, Morganroth J (1977) Electrocardiographic left atrial enlargement: electrophysiologic, echocardiographic, and hemodynamic correlates. Am J Cardiol 39:967–971PubMedCrossRef
17.
Zurück zum Zitat Kochiadakis GE, Parthenakis FI, Zuridakis EG, Rombola AT, Chrysostomakis SI, Vardas PE (1996) Is there increased sympathetic activity in patients with mitral valve prolapse? Pacing Clin Electrophysiol 19:1872–1876PubMedCrossRef Kochiadakis GE, Parthenakis FI, Zuridakis EG, Rombola AT, Chrysostomakis SI, Vardas PE (1996) Is there increased sympathetic activity in patients with mitral valve prolapse? Pacing Clin Electrophysiol 19:1872–1876PubMedCrossRef
18.
Zurück zum Zitat Leier CV, Jewell GM, Magorien RD, Wepsic RA, Schaal SF (1979) Interatrial conduction (activation) times. Am J Cardiol 44:442–446PubMedCrossRef Leier CV, Jewell GM, Magorien RD, Wepsic RA, Schaal SF (1979) Interatrial conduction (activation) times. Am J Cardiol 44:442–446PubMedCrossRef
19.
Zurück zum Zitat Levine RA, Stathogiannis E, Newell JB, Harrigan P, Weyman AE (1988) Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four-chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol 11:1010–1019PubMedCrossRef Levine RA, Stathogiannis E, Newell JB, Harrigan P, Weyman AE (1988) Reconsideration of echocardiographic standards for mitral valve prolapse: lack of association between leaflet displacement isolated to the apical four-chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol 11:1010–1019PubMedCrossRef
20.
Zurück zum Zitat Marks AR, Choong CY, Sanfilippo AJ, Ferré M, Weyman AE (1989) Identification of high-risk and low-risk subgroups of patients with mitral valve prolapse. N Engl J Med 320:1031–1036PubMedCrossRef Marks AR, Choong CY, Sanfilippo AJ, Ferré M, Weyman AE (1989) Identification of high-risk and low-risk subgroups of patients with mitral valve prolapse. N Engl J Med 320:1031–1036PubMedCrossRef
21.
Zurück zum Zitat Michelucci A, Bagliani G, Colella A, Pieragnoli P, Porciani MC, Gensini G, Padeletti L (2002) P-wave assessment: state of the art update. Card Electrophysiol Rev 6:215–220PubMedCrossRef Michelucci A, Bagliani G, Colella A, Pieragnoli P, Porciani MC, Gensini G, Padeletti L (2002) P-wave assessment: state of the art update. Card Electrophysiol Rev 6:215–220PubMedCrossRef
22.
Zurück zum Zitat Nishimura RA, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM, Tajik AJ (1985) Echocardiographically documented mitral valve prolapse: long-term follow-up of 237 patients. N Engl J Med 313:1305–1309PubMedCrossRef Nishimura RA, McGoon MD, Shub C, Miller FA Jr, Ilstrup DM, Tajik AJ (1985) Echocardiographically documented mitral valve prolapse: long-term follow-up of 237 patients. N Engl J Med 313:1305–1309PubMedCrossRef
23.
Zurück zum Zitat Pasternac A, Tubau JF, Puddu PE, Król RB, de Champlain J (1982) Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med 73:783–789PubMedCrossRef Pasternac A, Tubau JF, Puddu PE, Król RB, de Champlain J (1982) Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med 73:783–789PubMedCrossRef
24.
Zurück zum Zitat Rubler S, Shah NN, Moallem A (1976) Comparison of left atrial size and pulmonary capillary pressure with P-wave of electrocardiogram. Am Heart J 92:73–78PubMedCrossRef Rubler S, Shah NN, Moallem A (1976) Comparison of left atrial size and pulmonary capillary pressure with P-wave of electrocardiogram. Am Heart J 92:73–78PubMedCrossRef
25.
Zurück zum Zitat Taçoy G, Balcioğlu AS, Arslan U, Durakoğlugil E, Erdem G, Ozdemir M, Cengel A (2007) Effect of metoprolol on heart rate variability in symptomatic patients with mitral valve prolapse. Am J Cardiol 99:1568–1570PubMedCrossRef Taçoy G, Balcioğlu AS, Arslan U, Durakoğlugil E, Erdem G, Ozdemir M, Cengel A (2007) Effect of metoprolol on heart rate variability in symptomatic patients with mitral valve prolapse. Am J Cardiol 99:1568–1570PubMedCrossRef
26.
Zurück zum Zitat Terechtchenko L, Doronina SA, Pochinok EM, Riftine A (2003) Autonomic tone in patients with supraventricular arrhythmia associated with mitral valve prolapse in young men. Pacing Clin Electrophysiol 26:444–446PubMedCrossRef Terechtchenko L, Doronina SA, Pochinok EM, Riftine A (2003) Autonomic tone in patients with supraventricular arrhythmia associated with mitral valve prolapse in young men. Pacing Clin Electrophysiol 26:444–446PubMedCrossRef
27.
Zurück zum Zitat Tükek T, Akkaya V, Atilgan D, Demirel E, Ozcan M, Güven O, Korkut F (2001) Effect of left atrial size and function on P-wave dispersion: a study in patients with paroxysmal atrial fibrillation. Clin Cardiol 24:676–680PubMedCrossRef Tükek T, Akkaya V, Atilgan D, Demirel E, Ozcan M, Güven O, Korkut F (2001) Effect of left atrial size and function on P-wave dispersion: a study in patients with paroxysmal atrial fibrillation. Clin Cardiol 24:676–680PubMedCrossRef
28.
Zurück zum Zitat Waggoner AD, Adyanthaya AV, Quinones MA, Alexander JK (1976) Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria. Circulation 54:553–557PubMed Waggoner AD, Adyanthaya AV, Quinones MA, Alexander JK (1976) Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria. Circulation 54:553–557PubMed
Metadaten
Titel
P-Wave Dispersion and Heart Rate Variability in Children with Mitral Valve Prolapse
verfasst von
Kadir Babaoglu
Gürkan Altun
Köksal Binnetoğlu
Publikationsdatum
01.04.2011
Verlag
Springer-Verlag
Erschienen in
Pediatric Cardiology / Ausgabe 4/2011
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-011-9892-0

Weitere Artikel der Ausgabe 4/2011

Pediatric Cardiology 4/2011 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.